Funding Research

The Max Cure Foundation believes in funding innovative and novel childhood cancer research in an effort to find cures for the various forms of childhood cancer and to create less-toxic and more effective treatments for children and young adults diagnosed with cancer. More than $1.2 million has been donated to research primarily, among others, to fund The Immune Cell Therapy Lab at Memorial Sloan-Kettering Cancer Center.

Click here to read the 2016 report as to the progress that has been made over the past year. 

The Max Cure Fund

In May of 2007 when Max was just beginning his treatment, David and Annemarie asked Dr. Richard O’Reilly, the Chairman of Pediatric Oncology at MSKCC, and Dr. Paul Meyers, the Vice-Chairman of Pediatrics as to how best they can make a difference in the area of pediatric cancer. They wanted to know what they can do today in case the treatment for Max did not work. What alternative treatments would be made available to Max if the cancer was too strong and he did not respond to the treatment? Dr. O’Reilly discussed in detail that for the past decade he had been researching the use of alternative strategies to fight cancer. The alternative strategy has proven to work in other forms of cancer for adults. As Chairman of Pediatrics, his focus is on children and young adults and made it clear that his research has been proven to work but his access to funds are limited.

Immune cell therapies are an area of research that holds great promise in developing more precise, less toxic treatments for children and adolescents with cancer. With the support of Max Cure, the Cell Therapy Lab will be a crucial step in novel gene and cell-based therapies that are more effective in fighting pediatric cancers.

Dr. Richard O’Reilly, Chair of the Department of Pediatrics, Memorial Sloan-Kettering Cancer Center

The Plotkin’s started The Max Cure Fund to be held at MSKCC, which would be solely for the purpose of raising $5 million dollars to underwrite the cell therapy lab dedicated to the alternative treatments and researching the cancers in children and young adults that Dr. O’Reilly was spearheading. As of now, chemotherapy is the most effective way to treat and destroy cancer cells. However, chemotherapy is like a blunt instrument and does a poor job distinguishing the healthy cells from the cancer cells. While targeting the cancer cells, it destroys the good cells too. Our bodies have trillions of cells, and all it takes is for one bad cell to spread cancer. Dr. O’Reilly and Dr. Meyers firmly believe that while chemotherapy would still be used, it would be used on a smaller scale and our children can be protected from the unknown side effects of chemotherapy and radiation down the road. No one knows for sure the long-term negative effects of chemotherapy. But for now, it is the best we have. Think of chemotherapy as a sledgehammer; and this novel strategy the scalpel. In December of 2008 we started The Max Cure Foundation, a 501(c)(3) non-profit corporation to benefit pediatric cancer causes. While The Max Cure Fund at Memorial Sloan Kettering will be the primary beneficiary of The Max Cure Foundation, we will be supporting other worthy causes focused on pediatric cancer treatments and improving the lifestyle of children battling the disease.

Additional Research Funded

In addition, MCF has contributed $150,000 to Dr. Irwin Van Meir, researcher at Emory University in Atlanta seeking to find a cure for Ewing sarcoma (a rare form of cancer striking children and young adults) as part of two $100,000 collaborative grants with The Samuel Waxman Cancer Research Foundation (SWCRF). MCF has also donated $42,000 to Dr. Oren Becher at Duke University MedicalCenter seeking to find a cure for what is currently an incurable brain cancer afflicting children known as Diffuse Intrinsic Pontine Glioma (DIPG). Other donations have likewise been made in the area of research.

Give The Gift of Progress

Make a Donation Today to Fund Research

Make A Donation